Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies.

[1]  G. Navis,et al.  Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism. , 2011, Thrombosis research.

[2]  O. Phung,et al.  Statin use and the prevention of venous thromboembolism: a meta‐analysis , 2010, International journal of clinical practice.

[3]  Carol Coupland,et al.  Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database , 2010, BMJ : British Medical Journal.

[4]  W. Ageno,et al.  Statins, fibrates, and venous thromboembolism: a meta-analysis. , 2010, European heart journal.

[5]  A. Adler,et al.  Micronutrients and diabetic retinopathy a systematic review. , 2010, Ophthalmology.

[6]  A. Folsom,et al.  C-reactive protein and venous thromboembolism , 2009, Thrombosis and Haemostasis.

[7]  E. Fliers,et al.  Hypercoagulable state in Cushing's syndrome: a systematic review. , 2009, The Journal of clinical endocrinology and metabolism.

[8]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[9]  Markus Horneber,et al.  Green tea (Camellia sinensis) for the prevention of cancer. , 2009, The Cochrane database of systematic reviews.

[10]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[11]  P. Libby,et al.  A randomized trial of rosuvastatin in the prevention of venous thromboembolism. , 2009, The New England journal of medicine.

[12]  F. Rosendaal,et al.  HMG‐CoA reductase inhibitors, other lipid‐lowering medication, antiplatelet therapy, and the risk of venous thrombosis , 2009, Journal of thrombosis and haemostasis : JTH.

[13]  E. Horváth-Puhó,et al.  Arterial cardiovascular events, statins, low‐dose aspirin and subsequent risk of venous thromboembolism: a population‐based case‐control study , 2009, Journal of thrombosis and haemostasis : JTH.

[14]  G. Rutherford,et al.  The role of breast-feeding in the prevention of Helicobacter pylori infection: a systematic review. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  P. Ridker,et al.  An Evaluation of Candidate Genes of Inflammation and Thrombosis in Relation to the Risk of Venous Thromboembolism: The Women's Genome Health Study , 2009, Circulation. Cardiovascular genetics.

[16]  P. Wille-Jørgensen,et al.  Staged or simultaneous resection of synchronous liver metastases from colorectal cancer – a systematic review , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[17]  R. Hubbard,et al.  Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. , 2009, British journal of clinical pharmacology.

[18]  G. Marks,et al.  Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. , 2008, JAMA.

[19]  E. Oger,et al.  Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia? , 2008, Thrombosis research.

[20]  J. Cabane,et al.  Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. , 2007, The Journal of rheumatology.

[21]  I. Olkin,et al.  The case of the misleading funnel plot , 2006, BMJ : British Medical Journal.

[22]  T. Jefferson,et al.  Influenza vaccination for healthcare workers who work with the elderly. , 2006, The Cochrane database of systematic reviews.

[23]  S. Kahn,et al.  The relationship between inflammation and venous thrombosis , 2005, Thrombosis and Haemostasis.

[24]  Gordon H Guyatt,et al.  Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system , 2005, BMC health services research.

[25]  I. Pabinger,et al.  Inflammation in patients with lupus anticoagulant and implications for thrombosis. , 2005, The Journal of rheumatology.

[26]  E. Oger,et al.  Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital‐based case–control study , 2004, Fundamental & clinical pharmacology.

[27]  J. Ray Why might statins prevent venous thromboembolism: what needs to be done to know more? , 2002, Expert opinion on investigational drugs.

[28]  E. Vittinghoff,et al.  Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS) , 2002, Circulation.

[29]  H. Jick,et al.  Statins and the risk of idiopathic venous thromboembolism. , 2002, British journal of clinical pharmacology.

[30]  A. Laupacis,et al.  Use of statins and the subsequent development of deep vein thrombosis. , 2001, Archives of internal medicine.

[31]  Jonathan A C Sterne,et al.  Sifting the evidence—what's wrong with significance tests? , 2001, BMJ : British Medical Journal.

[32]  G H Guyatt,et al.  A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.

[33]  Jacob Cohen A Coefficient of Agreement for Nominal Scales , 1960 .